What does very high HDL cholesterol mean?

Very high HDL cholesterol (above 100 mg/dL) is generally protective but may indicate underlying conditions like genetic disorders or alcohol use. Most people benefit from higher HDL levels for heart health.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

High-density lipoprotein (HDL) cholesterol is often called "good cholesterol" because it helps remove harmful cholesterol from your arteries and transport it to your liver for disposal. While most people focus on lowering their "bad" LDL cholesterol, having high HDL levels is generally considered beneficial for cardiovascular health. But what happens when your HDL cholesterol is very high? Understanding what extremely elevated HDL levels mean can help you make informed decisions about your health and determine whether further investigation is needed.

Understanding HDL Cholesterol Levels

HDL cholesterol levels are measured in milligrams per deciliter (mg/dL) of blood. The standard reference ranges help healthcare providers assess cardiovascular risk and overall lipid profile health. Understanding where your levels fall can provide valuable insights into your metabolic health.

According to the American Heart Association and National Cholesterol Education Program, HDL cholesterol levels are categorized as follows: less than 40 mg/dL for men and less than 50 mg/dL for women is considered low and increases heart disease risk. Levels between 40-59 mg/dL are considered borderline, while 60 mg/dL and above is considered high and protective against heart disease.

HDL Cholesterol Level Categories and Health Implications

HDL Level (mg/dL)CategoryCardiovascular RiskHealth Implications
Men: <40, Women: <50Men: <40, Women: <50LowIncreased RiskHigher risk of heart disease and stroke
40-5940-59 mg/dLBorderlineModerate RiskAverage cardiovascular protection
60-7960-79 mg/dLHighProtectiveGood cardiovascular protection
80-10080-100 mg/dLVery HighHighly ProtectiveExcellent cardiovascular protection
>100>100 mg/dLExtremely HighVariableMay warrant medical evaluation

HDL cholesterol levels should be interpreted alongside other cardiovascular risk factors and overall health status.

What Constitutes "Very High" HDL

While there's no universally agreed-upon definition of "very high" HDL cholesterol, most cardiologists consider levels above 100 mg/dL to be exceptionally elevated. Some research suggests that HDL levels above 80-90 mg/dL warrant closer examination, particularly if they represent a significant increase from previous measurements.

The key is understanding your individual baseline and any changes over time. A sudden spike in HDL cholesterol, even if it's still within a "healthy" range, may be more significant than consistently high levels that have remained stable for years.

The Protective Role of HDL Cholesterol

HDL cholesterol serves several crucial functions in maintaining cardiovascular health. Its primary role involves reverse cholesterol transport, where HDL particles pick up excess cholesterol from peripheral tissues and arterial walls, transporting it back to the liver for processing and elimination.

Beyond cholesterol transport, HDL provides anti-inflammatory and antioxidant benefits. It helps reduce inflammation in blood vessel walls, prevents the oxidation of LDL cholesterol (which makes LDL more harmful), and supports endothelial function—the health of the inner lining of blood vessels.

Cardiovascular Protection

Research consistently shows that higher HDL cholesterol levels are associated with lower risk of heart disease and stroke. For every 1 mg/dL increase in HDL cholesterol, cardiovascular disease risk decreases by approximately 2-3%. This protective effect appears to be strongest in the range of 40-80 mg/dL, with diminishing returns at extremely high levels.

HDL also helps maintain healthy blood pressure and supports proper blood clotting function. These mechanisms work together to create a comprehensive cardiovascular protection system that extends beyond simple cholesterol management.

Causes of Very High HDL Cholesterol

Several factors can contribute to exceptionally high HDL cholesterol levels. Understanding these causes helps determine whether elevated levels are beneficial or potentially concerning.

Genetic Factors

Genetic variations play a significant role in HDL cholesterol levels. Some people inherit genes that naturally produce higher amounts of HDL cholesterol or create more efficient HDL particles. Familial hyperalphalipoproteinemia is a rare genetic condition that causes extremely high HDL levels, sometimes exceeding 150 mg/dL.

Mutations in genes like CETP (cholesteryl ester transfer protein) can also lead to elevated HDL levels. While these genetic variations often provide cardiovascular protection, they may occasionally be associated with other health considerations that require monitoring.

Lifestyle and Environmental Factors

Regular aerobic exercise is one of the most effective ways to raise HDL cholesterol naturally. Endurance athletes and highly active individuals often have HDL levels well above average, sometimes reaching 80-100 mg/dL or higher. This exercise-induced elevation is generally considered beneficial.

Moderate alcohol consumption can also increase HDL cholesterol levels. However, excessive alcohol intake can lead to very high HDL levels that may not provide the same protective benefits and can be associated with other health risks including liver disease and increased triglycerides.

Medical Conditions and Medications

Certain medical conditions can cause elevated HDL cholesterol. Hyperthyroidism accelerates metabolism and can increase HDL production. Chronic liver disease may alter lipid metabolism, sometimes resulting in higher HDL levels. Primary biliary cholangitis, an autoimmune liver condition, is particularly associated with very high HDL cholesterol.

Some medications can also raise HDL levels, including certain blood pressure medications, hormone replacement therapy, and some cholesterol-lowering drugs. If you've recently started new medications and notice changes in your cholesterol levels, discuss this with your healthcare provider.

When Very High HDL Might Be Concerning

While high HDL cholesterol is generally beneficial, extremely elevated levels may sometimes warrant investigation. Understanding when high HDL might signal underlying health issues helps ensure appropriate medical evaluation.

Potential Health Implications

Some research suggests that extremely high HDL cholesterol (above 100 mg/dL) may not provide additional cardiovascular benefits and could occasionally be associated with increased mortality risk. However, this research is still evolving, and the relationship is complex.

Very high HDL levels might indicate dysfunctional HDL particles that don't perform their protective functions effectively. In some cases, these particles may even become pro-inflammatory rather than anti-inflammatory. Additionally, extremely high HDL could be a marker for underlying conditions that require medical attention.

Red Flags to Watch For

Sudden increases in HDL cholesterol, particularly if accompanied by other symptoms, may warrant medical evaluation. Signs that might indicate underlying issues include unexplained weight loss, fatigue, changes in appetite, abdominal pain, or yellowing of the skin or eyes.

If your HDL cholesterol has increased dramatically without obvious lifestyle changes, or if it's accompanied by abnormal liver enzymes or other concerning lab values, your healthcare provider may recommend additional testing to rule out underlying conditions.

Monitoring and Managing HDL Cholesterol

Regular monitoring of your complete lipid profile, including HDL cholesterol, provides valuable insights into your cardiovascular health and helps track changes over time. Understanding your individual patterns and trends is more important than focusing on single test results.

Comprehensive cholesterol testing should include total cholesterol, LDL cholesterol, HDL cholesterol, and triglycerides. Advanced testing may also include apolipoprotein measurements and particle size analysis, which provide additional insights into cardiovascular risk. Regular monitoring allows you to track the effectiveness of lifestyle interventions and identify any concerning changes early.

Lifestyle Optimization

Even if your HDL cholesterol is already high, maintaining healthy lifestyle habits supports overall cardiovascular health. Regular aerobic exercise, maintaining a healthy weight, avoiding smoking, and following a heart-healthy diet rich in omega-3 fatty acids can help optimize your entire lipid profile.

Focus on the quality of your HDL cholesterol, not just the quantity. A Mediterranean-style diet with plenty of olive oil, nuts, fish, and vegetables supports the production of functional HDL particles that provide maximum cardiovascular protection.

Working with Healthcare Providers

If you have very high HDL cholesterol, working with your healthcare provider helps ensure appropriate evaluation and monitoring. They can assess whether your elevated levels are beneficial or require further investigation based on your individual health profile and risk factors.

Your provider may recommend additional testing if your HDL levels are extremely high, including liver function tests, thyroid function assessment, or genetic testing. They can also help you understand how your HDL cholesterol fits into your overall cardiovascular risk profile and whether any interventions are needed.

Comprehensive Health Assessment

Very high HDL cholesterol should be evaluated in the context of your complete health picture. This includes assessing other cardiovascular risk factors like blood pressure, diabetes risk, family history, and inflammatory markers. A comprehensive approach ensures that elevated HDL levels are properly interpreted and managed.

Regular follow-up testing helps track changes over time and ensures that any underlying conditions are identified and treated appropriately. Your healthcare provider can help you develop a monitoring schedule that's appropriate for your individual situation.

Taking Control of Your Cardiovascular Health

Very high HDL cholesterol is generally a positive finding that indicates good cardiovascular health, but understanding the underlying causes and ensuring appropriate monitoring is important for optimal health outcomes. Whether your elevated HDL levels are due to genetics, lifestyle factors, or other causes, staying informed and working with healthcare providers ensures you're making the best decisions for your long-term health.

Remember that cholesterol management is just one aspect of cardiovascular health. Maintaining a healthy lifestyle, managing stress, getting adequate sleep, and staying physically active all contribute to optimal heart health regardless of your specific cholesterol numbers.

References

  1. Gordon, T., Castelli, W. P., Hjortland, M. C., Kannel, W. B., & Dawber, T. R. (1977). High density lipoprotein as a protective factor against coronary heart disease: the Framingham Study. The American Journal of Medicine, 62(5), 707-714.[PubMed]
  2. Madsen, C. M., Varbo, A., & Nordestgaard, B. G. (2017). Extreme high high-density lipoprotein cholesterol is paradoxically associated with high mortality in men and women: two prospective cohort studies. European Heart Journal, 38(32), 2478-2486.[PubMed]

Was this article helpful?

Frequently Asked Questions

How can I test my HDL cholesterol at home?

You can test your HDL cholesterol at home with SiPhox Health's Heart & Metabolic Program This CLIA-certified program includes comprehensive cholesterol testing including HDL, LDL, total cholesterol, and triglycerides, providing lab-quality results from the comfort of your home.

What is considered very high HDL cholesterol?

HDL cholesterol levels above 100 mg/dL are generally considered very high, though some experts consider levels above 80-90 mg/dL to be exceptionally elevated. The key is understanding your individual baseline and any significant changes over time.

Is very high HDL cholesterol dangerous?

Very high HDL cholesterol is usually beneficial and protective against heart disease. However, extremely elevated levels (above 100 mg/dL) may occasionally warrant medical evaluation to rule out underlying conditions like genetic disorders or liver disease.

What causes HDL cholesterol to be very high?

Very high HDL cholesterol can be caused by genetic factors, regular intense exercise, moderate alcohol consumption, certain medications, or medical conditions like hyperthyroidism or liver disease. Most causes are benign, but sudden increases should be evaluated by a healthcare provider.

How often should I test my cholesterol levels?

Most experts recommend testing cholesterol levels every 3-6 months if you're actively monitoring cardiovascular health or making lifestyle changes. Annual testing may be sufficient for those with stable, healthy levels.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details